Elanco Animal Health Quarterly Cash Flow Statement
NYSE: ELANHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Elanco Animal Health free cash flow
In the quarter ended Jun 30, 2026, Elanco Animal Health generated $277.0 million of operating cash flow and spent $33.0 million on capital expenditures. That left free cash flow of $244.0 million, a free-cash-flow margin of 17.8% of revenue. Free cash flow was up 35.6% from the prior year's $180.0 million.
Summary generated from market data by MetaCap's automated system. Methodology
Elanco Animal Health cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 54.00M | 57.00M | -276.00M | -34.00M | 11.00M | 67.00M | -8.00M | 364.00M | -50.00M | 32.00M | -141.00M | -1.10B |
| Net Income growth (YoY) | +390.91% | -14.93% | — | -109.34% | — | +109.38% | — | — | — | -68.93% | — | — |
| Depreciation & Amortization | 171.00M | 172.00M | 174.00M | 176.00M | 169.00M | 161.00M | 164.00M | 170.00M | 162.00M | 166.00M | 171.00M | 173.00M |
| Stock-Based Compensation | 20.00M | 21.00M | 16.00M | 17.00M | 20.00M | 15.00M | 15.00M | 15.00M | 14.00M | 11.00M | 15.00M | 10.00M |
| Change in Working Capital | 24.00M | -263.00M | — | 59.00M | 52.00M | -237.00M | — | 248.00M | 22.00M | -177.00M | — | 27.00M |
| Operating Cash Flow | 277.00M | 13.00M | 108.00M | 219.00M | 237.00M | -4.00M | 177.00M | 162.00M | 200.00M | 2.00M | 157.00M | 198.00M |
| Capital Expenditures | -33.00M | -51.00M | -62.00M | -92.00M | -57.00M | -65.00M | -47.00M | -42.00M | -34.00M | -24.00M | -41.00M | -33.00M |
| Investing Cash Flow | -110.00M | -60.00M | -64.00M | -101.00M | -56.00M | -58.00M | -90.00M | 1.24B | -33.00M | 37.00M | -35.00M | -36.00M |
| Debt Issued | — | — | 2.11B | — | — | — | 0 | — | — | — | 0 | 0 |
| Debt Repaid | -73.00M | -16.00M | -2.11B | -188.00M | -361.00M | -13.00M | -13.00M | -1.56B | -12.00M | -13.00M | -14.00M | -356.00M |
| Financing Cash Flow | -74.00M | -65.00M | -18.00M | -153.00M | -156.00M | 52.00M | -32.00M | -1.34B | -93.00M | -27.00M | -139.00M | -157.00M |
| Net Change in Cash | 102.00M | -117.00M | 40.00M | -34.00M | 52.00M | 19.00M | -22.00M | 74.00M | 71.00M | -7.00M | -17.00M | 2.00M |
| Free Cash Flow | 244.00M | -38.00M | 46.00M | 127.00M | 180.00M | -69.00M | 130.00M | 120.00M | 166.00M | -22.00M | 116.00M | 165.00M |
This table shows 12 quarterly periods of Elanco Animal Health's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ELAN's reporting calendar. What is a cash flow statement?